(Q35192186)

7 August 2017

1 reference

title

Development of RTS,S/AS02: a purified subunit-based malaria vaccine candidate formulated with a novel adjuvant (English)

1 reference

7 August 2017

0 references

1 reference

1 reference

2

D Gray Heppner

1 reference

7 August 2017

Nathalie Garçon

1

1 reference

PubMed ID

12899574

7 August 2017

Joe Cohen

series ordinal

3

1 reference

7 August 2017

1 April 2003

1 reference

Expert Review of Vaccines

7 August 2017

1 reference

7 August 2017

2

1 reference

7 August 2017

231-238

1 reference

7 August 2017

2

1 reference

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

7 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.231

Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.231

The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.231

Adjuvants--a classification and review of their modes of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.231

Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.231

T cells as mediators of protective immunity against liver stages of Plasmodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.231

Cytotoxic T cells specific for the circumsporozoite protein of plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.2.231

21 January 2018

Identifiers

DOI

10.1586/14760584.2.2.231

1 reference

7 August 2017

1 reference

PubMed ID

12899574